Effect of hysterectomy on ovarian function: a systematic review and meta-analysis

Table 1 Summarized characteristics of 14 selected studies

First author	Year	PMID	Study design	Country	Sample size	Indicators	Evaluation time after surgery	NOS	RoB 2
Atabekoğlu	2012	22,268,398	Prospective cohort study	Turkey	42	AMH	4 m	7	-
Chalmers	2002	12,626,216	Prospective cohort study	Scotland	90	FSH	6 m, 1y, 2y	7	-
Chan	2005	22,268,398	Cross-sectional study	China	30	FSH	43 m (26 m – 53 m)	6	-
Cho	2021	34,300,243	Prospective cohort study	Korea	79	AMH	1w, 2 m, 6 m	6	-
Czuczwar	2018	29,859,107	Prospective cohort study	Poland	53	AMH, FSH, inhibin B, E2	3 m	7	-
Halmesmaki	2007	17,329,045	RCT	Finland	82	Inhibin B	6 m, 1y	-	High
Halmesmäki	2004	1,474,718	RCT	Finland	236	FSH	6 m, 1y	-	High
Hovsepian	2006	16,868,163	Retrospective cohort	USA	22	FSH	1 m, 3 m, 6 m	6	-
Kaiser	1989	2,500,073	Cross-sectional study	Germany	222	FSH,LH,E2	2-10y	5	-
Nahas	2003	12,737,673	Prospective cohort study	Brazil	61	FSH, inhibin B, LH, E2	6 m, 1y	7	-
Qu	2010	20,129,332	Prospective cohort study	China	60	FSH, inhibin B, LH, E2	1w, 3 m, 6 m	6	-
Trabuco	2016	27,054,925	Prospective cohort study	USA	320	AMH	1y	7	-
Wang	2013	24,172,648	Prospective cohort study	China	70	AMH, FSH, LH	2d, 3 m	7	-
Xiangying	2006	16,857,658	Prospective cohort study	China	90	FSH, LH, E2	5d, 1 m, 3 m	7	-

Annotation: NOS the Newcastle–Ottawa Scale checklist, RoB 2 version 2 of the Cochrane risk-of-bias tools, RCT randomized controlled trial, AMH anti-müllerian hormone, FSH follicle stimulating hormone, E2 estradiol, LH luteinizing hormone

ISSN: 1757-2215